Butler National director granted 3,197 shares
Director Julie Marie Bowen received an equity grant in Butler National, increasing her directly held common shares.
Rhea-AI Filing Summary
BUTLER NATIONAL CORP (BUKS) reported that director Julie Marie Bowen received a grant or award of 3,197 shares of Butler National common stock on September 21, 2026 at a reference value of $3.91 per share.
After this acquisition, she holds 29,932 shares of Butler National common stock directly, and no Rule 10b5-1 trading plan is reported for this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,197 shares
Grant/Award
1 txn
Insider
Bowen Julie Marie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Butler National Common Stock | 3,197 | $3.91 | $13K |
Holdings After Transaction:
Butler National Common Stock — 29,932 shares (Direct)
Key Figures
Shares granted: 3,197 shares
Grant reference price: $3.91 per share
Shares held after transaction: 29,932 shares
3 metrics
Shares granted
3,197 shares
Grant or award of Butler National common stock on September 21, 2026
Grant reference price
$3.91 per share
Reference value for the 3,197-share grant on September 21, 2026
Shares held after transaction
29,932 shares
Direct holdings of Julie Marie Bowen after the September 21, 2026 grant
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BUKS report for director Julie Marie Bowen?
The company reported that director Julie Marie Bowen received a grant or award of 3,197 shares of Butler National common stock on September 21, 2026 at a reference value of $3.91 per share.
Was the Butler National (BUKS) insider grant made under a Rule 10b5-1 plan?
No. The filing indicates the Rule 10b5-1 checkbox is not selected, so this reported grant to Julie Marie Bowen was not made under a Rule 10b5-1 trading plan.
What type of insider transaction did BUKS disclose for September 21, 2026?
On September 21, 2026, Butler National disclosed a grant or award acquisition of 3,197 shares of common stock by director Julie Marie Bowen, rather than an open-market purchase or sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.